Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05551195 · ClinicalTrials.gov registry record · NA
[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]
A NA study, sponsored by Woebot Health.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05551195: Clinical Trial NA study, sponsored by Woebot Health.
NCT05551195 is a NA study that was terminated before completion, run by Woebot Health. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05551195, a NA study, was terminated before completion, sponsored by Woebot Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study evaluates the efficacy of two digital therapeutics, WB001 and ED001, on depressive symptoms among women diagnosed with postpartum depression.
Primary Outcome
Measure of depression. This is a 6-item questionnaire, where total scores range from 0 to 22, with higher scores indicating greater severity of depression.
Interventions
- DEVICE WB001
- DEVICE ED001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2022-11-16 |
| Est. Completion | 2023-05-10 |
| Phase | NA |
Why NCT05551195 stopped before completion
NCT05551195 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which WB001 is the first listed.
NCT05551195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05551195 about?
NCT05551195 is a clinical study titled "[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]". This study evaluates the efficacy of two digital therapeutics, WB001 and ED001, on depressive symptoms among women diagnosed with postpartum depression.
What is the current status of trial NCT05551195?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2022-11-16. Estimated completion is 2023-05-10.
What interventions are being tested in trial NCT05551195?
The interventions under investigation include: WB001 (DEVICE), ED001 (DEVICE).
Who is sponsoring clinical trial NCT05551195?
This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05551195's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI